Medical Device testing Specialist

Robeauté is redefining the future of brain therapies through the first microrobotic platform designed to navigate the human brain with unprecedented precision. This new generation of medical microrobots will be able to diagnose, treat, and monitor the brain from within, overcoming the persistent limitations in treating neurological diseases that affect more than one in three people worldwide. Since its founding in 2017, Robeauté has filed more than 50 patent applications. We recently raised €27…